Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Business Today

D-STREET ANGELS

THE NEXT TIME you look at the stock market ticker and wonder which bull or bear is moving the Street, know that quite a few big-time investors also hunt in the multiverse. They are betting on the parallel world of yet-to-be-listed start-ups driven by entrepreneurs with dreams of changing the way we do things, talking of angels (investors) and fighting demons (of negative cash flows).

Some of these market veterans have seen 100x returns, some the gut-wrenching thrill of losing everything, and some are in it also because they can do all this while mentoring founders with an idea but no idea of running a business.

From legends such as the late Rakesh Jhunjhunwala to Vijay Kedia, Ashish Kacholia, Mukul Mahavir Agrawal, and Ashish Dhawan to Safir Anand and Ambareesh Baliga, all have invested in the start-up space. These big guns hunt for pure-play themes such as cybersecurity, 3D printing, fantasy games, hi-tech, insurtech, or shared office spaces, among others. All are hard to find in secondary markets. The lure? A start-up gives investors a chance to ride the innovation wave and make mind-boggling returns if it clicks. And then debuts in the secondary market. Take this: the listing of India’s first pure-play cybersecurity firm, TAC Infosec, turned Vijay Kedia and his son Ankit’s angel investment of ₹45 lakh (for a 20% stake) into more than ₹40 crore in a little over six years when the firm debuted on the bourses in April 2024.

A RISKY PROPOSITION

Vijay Kedia, a Mumbai-based investor whose listed holdings were worth ₹1,650 crore as of May 24, 2024, is known for picking quality shares on stock exchanges at an early stage. His start-up portfolio shows he is bullish on AI firms, tutoring services, and manufacturers of fibre 3D printers, among others. Tracxn, which tracks start-ups from seeds to unicorns, says Kedia held an 8.69% stake in Onward Assist, an AI-powered platform for cancer diagnostics. He

You’re reading a preview, subscribe to read more.

More from Business Today

Business Today3 min read
Looking East
ITS GDP IS just 12.5% the size of India’s, but the troubles from the unrest in Bangladesh with the resignation and flight of former Prime Minister Sheikh Hasina could still impact the Indian economy. An interim government has been formed headed by No
Business Today7 min read
Nursing Wockhardt Back To Health
HABIL KHORAKIWALA HAS seen more than his fair share of ups and downs in the nearly 60 years since he founded the Mumbai-based pharmaceuticals company Wockhardt in 1967. But even so, the closure of the company’s US-based manufacturing facility at Mort
Business Today1 min read
What’s The Cure?
STRATEGIC REFOCUSSING THE SALE OF ITS NUTRITION BUSINESS AND PARTS OF ITS HOSPITAL CHAIN ALLOWED THE COMPANY TO STREAMLINE OPERATIONS AND FOCUS ON CORE PHARMACEUTICAL AND BIOTECHNOLOGY BUSINESSES R&D INVESTMENTS CONTINUED INVESTMENT IN RESEARCH AND D

Related Books & Audiobooks